In focus · trending topic

Treatment-Free Remission

1 stories · following the connections

MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna

By Nasdaq OMXDec 22, 2017, 11:02 PM UTC